Vaginal estrogen tablets were not associated with increased risk of recurrent ischemic stroke in postmenopausal women with prior stroke.

Review some of the top stories from the Contemporary OB/GYN website over the past week and catch up on anything you may have missed.

A new study reveals that restrictive post-Dobbs abortion laws are preventing doctors from providing necessary care, resulting in avoidable harm to pregnant patients.

Panelists discuss how new FDA-approved treatments like zuranolone offer rapid onset options for postpartum depression, while monitoring effectiveness requires regular follow-up, rescreening, symptom assessment, and addressing global factors like sleep support and breastfeeding pressures.

Panelists discuss how treatment barriers include limited prescriptive access and long wait times, while successful treatment plans require assessing severity levels, maternal functioning, support systems, and incorporating follow-up care with appropriate interventions based on the patient’s specific needs.

A new study finds that cefazolin significantly reduces infection risk after planned cesarean delivery compared to clindamycin plus gentamicin.

A study found that 11% of intrauterine device removals have complications, with greater rates among Spanish-speaking patients.

Biennial HPV testing and higher vaccination rates could help South Korea eliminate cervical cancer up to a decade earlier than current policy.

Panelists discuss how the drospirenone/estetrol (E4) pill with 14.2 mg of estrogen provides effective contraception with a long half-life progestin that accommodates typical user behavior, while explaining that milligram vs microgram dosing reflects different estrogen metabolism rather than higher exposure.

Panelists discuss how the norethindrone acetate/ethinyl estradiol pill with 10 mcg of estrogen became the best-selling branded pill in the US due to its effective 24/2/2 formulation that minimizes bleeding issues through reduced placebo days and low-dose estrogen support.

An expert statement updates fracture prevention strategies for postmenopausal women with breast cancer receiving aromatase inhibitor therapy.

Epigenetic aging raises colorectal cancer risk in postmenopausal women, but higher fruit and vegetable intake may help offset this risk.

A new study highlights the need for trauma-informed care in obstetrics to improve outcomes and reduce racial disparities.

A new case series highlights technosphere insulin as an effective alternative to rapid-acting insulin analogs for controlling postprandial blood glucose during pregnancy.

OTC oral contraceptives boost access, with more women starting effective birth control, especially uninsured and rural populations.

A new review highlights proven strategies, including immediate pushing, epidural use, and warm compresses, for improving outcomes during vaginal delivery.

Hypertensive disorders in pregnancy affect fetal growth differently by sex, with males prioritizing growth and females adapting via placental development.

A new study finds women with pregnancy complications such as preeclampsia or preterm birth face significantly increased stroke risk at a younger age.

By analyzing electronic health records, researchers such as Marina Sirota, PhD, and Umair Khan have uncovered hundreds of conditions linked to endometriosis.

An expert discusses how fezolinetant appears to have neutral effects on bone density and bone health based on current 52-week study data in postmenopausal women.

An expert discusses how the OASIS-3 subanalysis provides intriguing evidence for potential long-term bone health benefits from elinzanetant alongside vasomotor symptom treatment, warranting further research.

New research suggests pre-in vitro fertilization weight loss improve chances of natural conception, though effects on live birth remain unclear.

Review some of the top stories from the Contemporary OB/GYN website over the past week and catch up on anything you may have missed.

A new study using advanced pregnancy preference measures reveals that heavy alcohol use significantly increases the risk of unintended pregnancy, highlighting the need for personalized contraceptive support.

Counties with persistently low cervical cancer screening rates have nearly double the rates of late-stage diagnoses and mortality, study finds.